Fresenius Medical Care shares fell after the German dialysis specialist forecast flattish revenue and adjusted earnings in ...

Feb 24 (Reuters) - Fresenius Medical Care gave a cautious outlook for 2026 on Tuesday, sending its shares around 10% lower at ...

Fresenius Medical Care AG & Co. FMS reported fourth-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which ...

Feb 25 (Reuters) - German healthcare group Fresenius narrowly beat analysts' expectations for fourth-quarter adjusted revenue on Wednesday, helped by a better performance at its hospital operator unit ...

German healthcare group Fresenius forecast slightly higher sales for 2026 on Wednesday, falling short of market expectations, ...

As of Tuesday, February 24, Fresenius Medical Care AG’s FMS share price has dipped by 6.71%, which has investors questioning if this is right time to buy.

Feb 24 (Reuters) - Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income on Tuesday, helped by ...

Fresenius SE shares fell more than 3% on Wednesday after the German healthcare group issued a 2026 profit growth forecast that fell short of analyst expectations, ...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) used its fourth-quarter and full-year 2025 earnings call to highlight what ...

A Massachusetts-based company that operates dialysis centers across the country is set to close another location in rural ...

Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP in the U.S.

Management attributed the 2025 performance step-up to the successful execution of the FME25+ transformation program, which ...